The present invention relates to stable pharmaceutical composition of bilastine crystalline Form 3 comprising water insoluble diluent, disintegrant and one or more pharmaceutically acceptable excipients, wherein the composition is free of water soluble diluent. Also the present invention relates to process for prepa...